CSIMarket
 
Cerevel Therapeutics Holdings Inc   (NASDAQ: CERE)
 

Cerevel Therapeutics Holdings Inc's Suppliers Performance

CERE's Supply Chain




 
CERE Costs vs Sales of Suppliers Growth Revenues of Cerevel Therapeutics Holdings Inc's Suppliers, deteriorated by -6.13 % compared to the same quarter a year ago, from the previous quarter, sales fell by -5.27 %, while their net profit margin fell to 11.08 % year on year, Cerevel Therapeutics Holdings Inc's Suppliers improved sequentially profit margin to -5.27 %,

More on CERE Suppliers



Cerevel Therapeutics Holdings Inc's Suppliers realized a deteriorated in sales by -6.13 % compared to the same quarter a year ago, from the previous quarter, sales fell by -5.27 %, while their net profit margin fell to 11.08 % year on year, Cerevel Therapeutics Holdings Inc's Suppliers improved sequentially profit margin to 11.08 %,

More on CERE Suppliers




Cerevel Therapeutics Holdings Inc's Comment on Supply Chain




CERE's Suppliers Net profit fell by CERE's Suppliers Net margin fell in Q1 to
-18.92 % 11.08 %
CERE's Suppliers Net profit fell by -18.92 %


CERE's Suppliers Net margin fell in Q1 to 11.08 %


Cerevel Therapeutics Holdings Inc's Suppliers Sales Growth in Q1 2024 by Industry

Suppliers from Chemical Manufacturing Industry -9.77 %   
Suppliers from Chemicals - Plastics & Rubber Industry -7.38 %   
Suppliers from Construction Raw Materials Industry -8.78 %   
Suppliers from Construction & Mining Machinery Industry -9.81 %   
Suppliers from Miscellaneous Manufacturing Industry -0.59 %   
Suppliers from Industrial Machinery and Components Industry -8.86 %   
Suppliers from Conglomerates Industry      2.72 %
Suppliers from Agricultural Production Industry -14.39 %   
Suppliers from Food Processing Industry -84.22 %   
Suppliers from Oil And Gas Production Industry -16.83 %   
Suppliers from Oil & Gas Integrated Operations Industry -5.84 %   
Suppliers from Property & Casualty Insurance Industry      22.93 %
Suppliers from Regional Banks Industry -5.78 %   
Suppliers from Commercial Banks Industry      10.95 %
Suppliers from Professional Services Industry -0.09 %   
Suppliers from Cruise and Shipping Industry  
Suppliers from Scientific & Technical Instruments Industry -3.41 %   
Suppliers from Railroads Industry -1.67 %   
Suppliers from Marine Transportation Industry      5.8 %
Suppliers from Natural Gas Utilities Industry -10.06 %   
Suppliers from Water Supply Industry      762.31 %
     





CERE's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Cerevel Therapeutics Holdings Inc 8,165.22 0.00 -460.47 260
Sunworks Inc 2.61 154.14 -62.50 80
Thermo Fisher Scientific Inc 245,446.18 46,336.00 6,989.00 125,000
First Financial Corporation 895.32 268.17 84.76 946
Arch Capital Group Ltd 33,425.50 19,232.00 4,692.00 8,000
Aspen Insurance Holdings Limited 0.00 3,219.60 340.20 13
SUBTOTAL 4,731,340.90 2,635,517.65 234,969.80 2,908,162
53 more Suppliers available

Sign in to see all suppliers for Cerevel Therapeutics Holdings Inc .



Sources: Cerevel Therapeutics Holdings Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Cerevel Therapeutics Holdings Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.